Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study explores antibiotic misuse

03.01.2005


If a runny nose and congested chest have you thinking of antibiotics, think again.



"For uncomplicated colds, zero are necessary; bronchitis, less than 10 percent are necessary; sore throats, maybe up to 10 to 15 percent of these patients need an antibiotic," says Dr. Jim Wilde, pediatric emergency medicine and infectious disease physician at the Medical College of Georgia. "Ninety to 95 percent of all infections are viral or low-acuity bacterial infections such as ear infections or sinus infections," says Dr. Wilde. Yet studies show that more than half of patients in the United States are taking bacteria-destroying antibiotics for colds, flu and bronchitis, all caused by viruses, says Dr. Wilde.

The worrisome balance sheet has Dr. Wilde, a self-professed foe of antibiotic misuse, regularly lecturing to health care providers, residents and students about proper use of antibiotics. Now he’s also a principal investigator on a National Institutes of Health-funded study seeking to educate providers as well as patients on the hazards of antibiotic misuse.


The net effect is we are losing the war, says Dr. Wilde, with the spread of antibiotic-resistant bacteria running ahead of production of new antibiotics to fight them. "If you look at the history of antibiotic use in the last 60 years and you look at the history of resistance in the last 60 years, one is about two years behind the other. As soon as a new antibiotic is introduced, bugs develop resistance to it. If it had not been for the fact that we have been developing more antibiotics in the last 50 years, we would be in big trouble right now. Even if you use antibiotics appropriately, bugs will still find a way to get around them, but we can delay the spread of resistance so we have more time to develop new antibiotics."

Dr. Wilde believes that without big change, antibiotics – needed to treat life-threatening conditions such as meningitis and pneumonia – may be useless within 50 years. "It’s a federal issue. We are in big trouble in this country if we don’t get our antibiotic use under control. Sounds alarmist? It’s not," says the physician, who in the last year has seen children in the emergency room with abscesses, or pus pockets, containing methycillin-resistant Staphylococcus aureus. In fact, a Web-based chat room for pediatric emergency specialists across the country is buzzing with talk of this antibiotic-resistant infection showing up in otherwise healthy children. "It’s nasty stuff and it’s because of inappropriate antibiotic use. This is just the tip of the iceberg," says Dr. Wilde

The NIH, in consultation with the Centers for Disease Control and Prevention, has funded a multi-year study designed to get a still-better handle on the extent of antibiotic misuse and the efficacy of educational programs designed to curb it.

MCG Medical Center and the Veterans Affairs Medical Center in Augusta are among 16 hospitals nationally participating in the four-year study. The first year looked at baseline antibiotic use rate in emergency rooms at study hospitals. Study coordinators, such as Helen Fain, study coordinator for MCG and the VA, pulled 250 charts from patients who came into the emergency room with respiratory illness and looked at how many got antibiotics. Each center also conducted follow up phone interviews with 50 of the patients asking questions such as whether they were satisfied with their visit, thought they needed antibiotics and understood why the doctor didn’t prescribe antibiotics if he didn’t.

Year two recently started and is about education, including stepping up Dr. Wilde’s educational forums with health care providers in the emergency room at MCG Medical Center as well as a patient-focused campaign that includes a bilingual kiosk in the emergency room lobby.

Posters in exam rooms explain simple truths such as the fact that bronchitis is a chest cold meaning no antibiotic is needed 90 percent of the time, says Dr. Wilde. Patient handouts developed by the CDC reinforce what conditions merit antibiotics and what happens when antibiotics are misused.

The interactive kiosk, in use in four of eight cities in the study, runs through scenarios with patients describing familiar respiratory ills to a doctor, then asks the user questions such as whether antibiotics kill viruses. The correct answer: "No."

The third year will determine whether availability of a blood test that helps identify the some 10 percent of bronchitis patients who have a bacterial and viral infection – a ’super’ infection that would benefit from an antibiotic – brings antibiotic use down. The final year will look at whether all the education has made a lasting difference. "I started my career as an infectious disease physician, so I’m the first to say, if you need an antibiotic, take one," says Dr. Wilde, and take it correctly, meaning keep taking the drug until it is gone, not just until symptoms disappear.

But in doctors’ offices and hospitals across the country, patients have come to expect antibiotics for viral infections and too many doctors are willing to give them, says Dr. Wilde. "We need to make sure we are educating the public so if they don’t get an antibiotic, they understand why."

Third-world countries, where severe physician shortages preclude prescriptions for antibiotics, already are living the nightmare of common infections that no longer have a treatment. "In this country, the most dangerous bacteria we worry about is vancomycin-resistant enterococcus, a really nasty bug that can cause bacterial heart infections, meningitis, sepsis, kidney abscesses and infections," says Dr. Wilde. "It kills a lot of people. It wasn’t even on the radar screen until about 15 years ago when enterococcus found a way to get around vancomycin. The research is clear: the more a hospital uses vancomycin, the higher the rates of VRE. We must limit vancomycin use to cases where it is necessary so we can slow the spread of VRE."

Toni Baker | EurekAlert!
Further information:
http://www.mcg.edu

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>